PELNSEPiramal Enterprises Limited· PharmaceuticalsHighNeutral
Announced Wed, 9 Jul · 11:21 IST

Piramal Enterprises Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) - Filing of Company Petition in Company Application no. CA(CAA) 113 of 2025 with Hon'ble National Company Law Tribunal, Mumbai Bench.

Nclt Scheme FiledStrategic Transactions View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Piramal Enterprises Limited has filed a Company Petition (CA(CAA) 113 of 2025) with the NCLT Mumbai Bench on 8th July 2025, seeking sanction for its composite scheme of arrangement with Piramal Finance Limited (formerly Piramal Capital & Housing Finance Limited) and their respective shareholders and creditors. The scheme was already approved by the requisite majority of equity shareholders and secured creditors of the Company at meetings held on 4th July 2025. The scheme is being filed under Sections 230 to 232 of the Companies Act, 2013. This is the next procedural step after shareholder and creditor approval, moving towards NCLT sanction.

Likely market impact

This filing advances the corporate restructuring between PEL and its subsidiary Piramal Finance, bringing it closer to completion pending NCLT approval. Shareholders should monitor NCLT hearing outcomes, as final sanction will determine the effective date and any changes to the shareholding or capital structure. Near-term stock movement may be limited as the approval pathway was largely anticipated after the July 4 voting results.